AI assistant
Sending…
MACROGENICS INC — Director's Dealing 2018
Jan 18, 2018
34129_dirs_2018-01-18_fdde0313-df34-43fa-a102-7ce93f14a7eb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2018-01-16
Reporting Person: Karrels James (SVP, CFO and Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-01-16 | Common Stock | M | 6516 | $0.94 | Acquired | 119847 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-01-16 | Employee stock option (right to buy) | $0.94 | M | 6516 | Disposed | 2018-04-09 | Common Stock (6516.0) | Direct |
Footnotes
F1: Owned jointly with reporting person's wife.
More from MACROGENICS INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18